CNK vs RGC

Cinemark Holdings, Inc.

(CNK) offers the better valuation at 26. 4x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cinemark Holdings, Inc. (CNK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Regencell Bioscience Holdings Limited (RGC) delivered a total return of +112.

9%, compared to +29. 3% for Cinemark Holdings, Inc. (CNK). Over 10 years, the gap is even starker: RGC returned +119. 3% versus CNK's -6. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cinemark Holdings, Inc.

(CNK) is the lower-risk stock at 0. 22β versus Regencell Bioscience Holdings Limited's 0. 72β — meaning RGC is approximately 231% more volatile than CNK relative to the S&P 500. On balance sheet safety, Regencell Bioscience Holdings Limited (RGC) carries a lower debt/equity ratio of 1% versus 9% for Cinemark Holdings, Inc. — giving it more financial flexibility in a downturn.

On earnings-per-share growth, the picture is similar: Regencell Bioscience Holdings Limited grew EPS 26.

9% year-over-year, compared to -49. 5% for Cinemark Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cinemark Holdings, Inc.

(CNK) is the more profitable company, earning 4. 4% net margin versus 0. 0% for Regencell Bioscience Holdings Limited — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNK leads at 11. 0% versus 0. 0% for RGC. At the gross margin level — before operating expenses — CNK leads at 18. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, CNK (1.

1% yield) pays a dividend. RGC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cinemark Holdings, Inc.

(CNK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 22), 1. 1% yield). Both have compounded well over 10 years (CNK: -6. 6%, RGC: +119. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CNK (Communication Services) and RGC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

CNK pays a dividend while RGC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.